CenterPoint Energy reported a solid earnings beat on October 27, lifted its 2026 EPS guidance and expanded its capital plan, yet the stock has slipped back below the 40‑week average and now trades under key swing‑zone resistance. The balance of evidence points to a neutral stance for the next two to six weeks, with low conviction because the rally that lifted the price is not yet stretched and the downside math still dominates.
Why it matters
The Q3 2026 earnings call showed adjusted EPS of $0.53, up from $0.50 a year earlier, and management raised 2026 EPS guidance to $1.90‑$1.92 while introducing 2027 guidance of $2.07‑$2.09, implying roughly 9% growth year‑over‑year. The company also announced a $4 billion increase to its 10‑year capital investment plan, now $70.7 billion through 2035. This upbeat guidance was already priced in; the stock rallied to a recent peak of $42.65 on November 2 before retreating to $40.81, a 4.3% drop from that high.
Sector‑wide, the utilities ETF XLU was flat over the past 50 days (+0.1%) and up 4.86% over the month, indicating the broader utilities space has not been a major driver of CNP’s move. The 5‑day attribution shows the stock underperformed the S&P 500 by 0.7 percentage points (‑0.57% vs. ‑1.02% for the market) and lagged XLU by 0.8 points, suggesting the recent decline is more stock‑specific than sector‑driven.
Analyst sentiment remains broadly bullish: 19 analysts rate the stock “buy” with a consensus target of $44.24, a mean upside of about 8% versus the current price. However, the price is still 7.8% below that mean target, and the spread between the low ($39) and high ($50) targets reflects considerable uncertainty. The market’s reaction to the earnings beat was muted, as volume was 84.9% below its 20‑day average, indicating limited participation.
Debate in the press is split. Barchart.com notes that CNP has underperformed the S&P 500 over the past year despite a 6% YTD gain, but still highlights the earnings beat as a positive catalyst ("bullish" stance, target $49) Barchart.com. Conversely, Scotiabank’s utility pick list places CNP among top picks, implying confidence in its growth prospects Investing.com. Neither source explains the recent price weakness, underscoring that the market has already digested the earnings narrative.
What the evidence says
Long‑term, the weekly trend remains down; the price sits below its 40‑week average and the 200‑day SMA at $41.65, a level that has acted as resistance in recent weeks. The thesis of a structural uptrend is therefore weakened, though the stock still holds above the 50‑day SMA ($39.46) and the RSI of 51.9 suggests no extreme momentum bias.
For the next two to six weeks, the balance of evidence leans neutral with low conviction. The assessment identifies one of four conviction points: a rally against the weekly downtrend that is not yet stretched, outperformance versus the S&P 500 over 50 days (+4.2%), and lagging XLU over the same period (‑0.8%). The downside breakout math points to a daily close below $40.07 as the trigger, with a stop at $41.63 and targets at $39.46 (R:R 0.4) and $38.58 (R:R 1.0). The 3‑to‑1 reward‑to‑risk ratio is not met, meaning the upside potential does not outweigh the downside risk under current conditions.
The strongest case against a neutral reading would be a sustained break above the 200‑day SMA at $41.65, which would signal the weekly trend ending and could reopen upside bias. However, the stock would need a weekly close above that level to invalidate the current stance, and the price is still 1.85 points below it, keeping the downside scenario more probable.
Levels that matter
The structure holds above the swing‑zone resistance at $41.40, a price where sellers have historically stepped in during rallies. Above that, the next resistance is the 200‑day SMA at $41.65, which also marks the level where the weekly trend would be considered ended if closed above on a weekly bar.
The breakout level for a downside move is a daily close under the swing‑zone support at $40.07. The math gives a stop at $41.63 (based on $41.40 plus a quarter of the 14‑day ATR of $0.93) and two targets: $39.46 (the 50‑day SMA) with a reward‑to‑risk of 0.4, and $38.58 (the next swing‑zone support) with a reward‑to‑risk of 1.0. Because the reward‑to‑risk does not reach 3‑to‑1, a price move to $36.62 (the 52‑week low) would be required to achieve that ratio.
What would change the picture
A weekly close above the 200‑day SMA at $41.65 would end the weekly downtrend and shift the balance of evidence toward a more positive outlook. A non‑price catalyst such as a major capital‑expenditure win or a regulatory approval that materially expands earnings would also tilt the narrative.
What to watch
- October 27 earnings release – focus on the adjusted EPS number and any revision to the 2026/2027 guidance.
- Sector moves: XLU performance and any utility‑specific regulatory news that could affect earnings.
- Valuation: consensus price target of $44.24 versus the current $40.81, a gap of roughly 8%.